Are you Dr. Simpson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 75 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
701 E El Camino Real
Mountain View, CA 94040Phone+1 650-934-7575
Summary
- Dr. Peter Simpson, MD is a gastroenterologist in Mountain View, California. He is currently licensed to practice medicine in California. He is affiliated with El Camino Health, Good Samaritan Hospital, and Mills-Peninsula Medical Center.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2003 - 2006
St Mary's Hospital and Medical CenterResidency, Internal Medicine, 2001 - 2002
University of California, Davis, School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2025- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 11 citationsHemoglobin A1C, Mean Glucose, and Persistence of Glycation Ratios in Insulin-Treated DiabetesNicholas B. Argento, Katherine Nakamura, Robert D. Sala, Peter Simpson
Endocrine Practice. 2014-03-01 - 57 citationsReference range and short- and long-term biological variation of interleukin (IL)-6, IL-17A and tissue necrosis factor-alpha using high sensitivity assaysJohn Todd, Peter Simpson, Joel Estis, Victoria Torres, Alan H.B. Wub
Cytokine. 2013-12-01 - 26 citationsA multicenter, prospective, randomized comparison of a novel signal transmission capsule endoscope to an existing capsule endoscopeEric Choi, Klaus Mergener, Carol E. Semrad, Laurel Fisher, David R. Cave
Gastrointestinal Endoscopy. 2013-08-01
Press Mentions
Complex Medicines: A Multi-Billion Pound Addition to UK IndustryJuly 19th, 2021- Alchemab and Medicines Discovery Catapult to Develop Landmark Novel Antibody Therapy for Huntington’s DiseaseMarch 16th, 2021
- UK Innovators Target Nanoparticles at Inoperable CancersDecember 18th, 2020
- Join now to see all
